| Dr Carmen Velazquez, | |
|
101 Ave San Patricio, Maramar Plaza Suite 1150, Guaynabo, PR 00968-2645 | |
| (787) 793-2623 | |
| (787) 793-2700 |
| Full Name | Dr Carmen Velazquez |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 26 Years |
| Location | 101 Ave San Patricio, Guaynabo, Puerto Rico |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104902162 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 13910 (Puerto Rico) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Auxilio Mutuo Hospital | Hato rey, PR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| San Patricio Physical Rehabilitation Center Psc | 5799840484 | 3 |
News Archive
Amgen Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Prolia™ (denosumab) for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy. Prolia, the first and only FDA-approved RANK Ligand inhibitor, is an every six month 60 mg subcutaneous injection administered by a health care professional.
House Republicans rejected the deal -; approved by the Senate before it adjourned for the holidays -; to extend the payroll tax cut. This event is the latest in a chain of ongoing congressional sagas marked by questions of what the government should fund and how it pay for it.
The ongoing COVID-19 pandemic has baffled researchers with its propensity to cause symptoms of largely unpredictable severity in the affected individuals. An exciting new study reports on the potential predictive value of platelet size in this situation. COVID-19 patients with severe disease often develop clots in vital organs, which leads to further complications. It is known that platelet size is a good indicator of activation.
MonoSol Rx, the developer of PharmFilm® technology and a drug delivery company specializing in proprietary pharmaceutical film products, and APR Applied Pharma Research s.a. ("APR") announced today an expansion of their relationship to identify and develop film formulations of prescription drug products beyond ondansetron and donepezil to include zolmitriptan. Zolmitriptan is currently commercially available for the acute treatment of migraine headache in adults, and facing initial patent expirations in 2012.
Sweet and bitter flavors are identified as soon as they are tasted, according to human neural and behavioral data published in eNeuro. The study provides new insight into how the brain rapidly detects and discriminates between potentially nutritious and toxic substances.
› Verified 9 days ago
| Entity Name | San Patricio Physical Rehabilitation Center Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477706646 PECOS PAC ID: 5799840484 Enrollment ID: O20090212000319 |
News Archive
Amgen Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Prolia™ (denosumab) for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy. Prolia, the first and only FDA-approved RANK Ligand inhibitor, is an every six month 60 mg subcutaneous injection administered by a health care professional.
House Republicans rejected the deal -; approved by the Senate before it adjourned for the holidays -; to extend the payroll tax cut. This event is the latest in a chain of ongoing congressional sagas marked by questions of what the government should fund and how it pay for it.
The ongoing COVID-19 pandemic has baffled researchers with its propensity to cause symptoms of largely unpredictable severity in the affected individuals. An exciting new study reports on the potential predictive value of platelet size in this situation. COVID-19 patients with severe disease often develop clots in vital organs, which leads to further complications. It is known that platelet size is a good indicator of activation.
MonoSol Rx, the developer of PharmFilm® technology and a drug delivery company specializing in proprietary pharmaceutical film products, and APR Applied Pharma Research s.a. ("APR") announced today an expansion of their relationship to identify and develop film formulations of prescription drug products beyond ondansetron and donepezil to include zolmitriptan. Zolmitriptan is currently commercially available for the acute treatment of migraine headache in adults, and facing initial patent expirations in 2012.
Sweet and bitter flavors are identified as soon as they are tasted, according to human neural and behavioral data published in eNeuro. The study provides new insight into how the brain rapidly detects and discriminates between potentially nutritious and toxic substances.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Carmen Velazquez, 101 Ave San Patricio, Maramar Plaza Suite 1150, Guaynabo, PR 00968-2645 Ph: (787) 793-2623 | Dr Carmen Velazquez, 101 Ave San Patricio, Maramar Plaza Suite 1150, Guaynabo, PR 00968-2645 Ph: (787) 793-2623 |
News Archive
Amgen Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Prolia™ (denosumab) for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy. Prolia, the first and only FDA-approved RANK Ligand inhibitor, is an every six month 60 mg subcutaneous injection administered by a health care professional.
House Republicans rejected the deal -; approved by the Senate before it adjourned for the holidays -; to extend the payroll tax cut. This event is the latest in a chain of ongoing congressional sagas marked by questions of what the government should fund and how it pay for it.
The ongoing COVID-19 pandemic has baffled researchers with its propensity to cause symptoms of largely unpredictable severity in the affected individuals. An exciting new study reports on the potential predictive value of platelet size in this situation. COVID-19 patients with severe disease often develop clots in vital organs, which leads to further complications. It is known that platelet size is a good indicator of activation.
MonoSol Rx, the developer of PharmFilm® technology and a drug delivery company specializing in proprietary pharmaceutical film products, and APR Applied Pharma Research s.a. ("APR") announced today an expansion of their relationship to identify and develop film formulations of prescription drug products beyond ondansetron and donepezil to include zolmitriptan. Zolmitriptan is currently commercially available for the acute treatment of migraine headache in adults, and facing initial patent expirations in 2012.
Sweet and bitter flavors are identified as soon as they are tasted, according to human neural and behavioral data published in eNeuro. The study provides new insight into how the brain rapidly detects and discriminates between potentially nutritious and toxic substances.
› Verified 9 days ago
Mrs. Joyce Marie Castro Gonzalez, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1 Calle San Miguel Apt 75, Guaynabo, PR 00966 Phone: 787-758-8383 Fax: 787-758-0105 | |
Dr. Jose Manuel Morales, M.D. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 35 Calle Juan C Borbon, Pmb 182 Ste 67, Guaynabo, PR 00969 Phone: 787-789-0564 | |
Dr. Eduardo Nadal-ortiz, M.D. Physical Medicine & Rehabilitation Medicare: May Accept Medicare Assignments Practice Location: 1019 Carretera 19 Doral Plaza Apt 10-m, Guaynabo, PR 00966 Phone: 787-605-6106 | |
Maricarmen Cruz, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 3rd Street 11-5, Alturas Torrimar, Guaynabo, PR 00969 Phone: 787-641-7582 | |
Dr. Irma I. Morales, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: Murano Luxury Apt., 1 Palma Real Avenue Apt. 1206, Guaynabo, PR 00969 Phone: 787-530-8841 Fax: 787-641-5716 | |
Jose A Baez Cordova, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 14b Calle Vanda, Los Filtros, Guaynabo, PR 00966 Phone: 787-273-7969 |